Entrada Therapeutics, Inc. (TRDA) stock
TRDANasdaqPharmaceutical PreparationsFiscal year ends December 31
$5.09−0.08 (-1.55%)
Close on Nov 13, 2026Market cap $198.19MP/E –Yield –
Entrada Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Entrada Therapeutics's price to book ratio was 0.9× on Nov 11, 2026, against 1.2× a year earlier. Over the last 5 years it ranged from 0.5× to 2.8×, with a median of 1.5×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.9× | −0.2 |
| 2025 | Dec 31, 2025 | 1.2× | −0.4 |
| 2024 | Dec 31, 2024 | 1.5× | −0.5 |
| 2023 | Dec 29, 2023 | 2.0× | +0.2 |
| 2022 | Dec 30, 2022 | 1.8× | – |
See a number that looks wrong?